Quality by Design characterization of the perfusion culture process for recombinant FVIII
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Jae | - |
dc.contributor.author | Paik, Sang Hoon | - |
dc.contributor.author | Han, Sang Kyul | - |
dc.contributor.author | Lee, Sunggeun | - |
dc.contributor.author | Jeong, Yoomin | - |
dc.contributor.author | Kim, Ji-youn | - |
dc.contributor.author | Kim, Chan Wha | - |
dc.date.accessioned | 2021-09-01T15:49:35Z | - |
dc.date.available | 2021-09-01T15:49:35Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-05 | - |
dc.identifier.issn | 1045-1056 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/65901 | - |
dc.description.abstract | A Quality by Design (QbD) concept was applied to characterize a cell culture process for production of the recombinant Factor VIII (rFVIII). We characterized the production bioreactor process and defined the design space by applying risk assessment to determine potential critical process parameters (CPPs) impacting critical quality attributes (CQAs). Characterization studies were subsequently performed using a qualified scaled-down model (SDM) and a multi-factorial design of experiment (DOE) approach to determine both the individual and combined impacts of the potential CPPs on CQAs. Among the operating parameters characterized, production temperature, production pH and a shift in the timing of production affected rFVIII activity and tyrosine sulfation level. Finally, we identified CPPs and established a design space for the cell culture process to identify appropriate conditions for routine manufacturing. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD | - |
dc.subject | VON-WILLEBRAND-FACTOR | - |
dc.subject | COAGULATION-FACTOR-VIII | - |
dc.subject | TYROSINE SULFATION | - |
dc.subject | B-DOMAIN | - |
dc.subject | IDENTIFICATION | - |
dc.subject | TEMPERATURE | - |
dc.subject | IMPROVEMENT | - |
dc.subject | PH | - |
dc.title | Quality by Design characterization of the perfusion culture process for recombinant FVIII | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chan Wha | - |
dc.identifier.doi | 10.1016/j.biologicals.2019.03.004 | - |
dc.identifier.scopusid | 2-s2.0-85063352781 | - |
dc.identifier.wosid | 000469891500006 | - |
dc.identifier.bibliographicCitation | BIOLOGICALS, v.59, pp.37 - 46 | - |
dc.relation.isPartOf | BIOLOGICALS | - |
dc.citation.title | BIOLOGICALS | - |
dc.citation.volume | 59 | - |
dc.citation.startPage | 37 | - |
dc.citation.endPage | 46 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | VON-WILLEBRAND-FACTOR | - |
dc.subject.keywordPlus | COAGULATION-FACTOR-VIII | - |
dc.subject.keywordPlus | TYROSINE SULFATION | - |
dc.subject.keywordPlus | B-DOMAIN | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | TEMPERATURE | - |
dc.subject.keywordPlus | IMPROVEMENT | - |
dc.subject.keywordPlus | PH | - |
dc.subject.keywordAuthor | Quality by Design (QbD) | - |
dc.subject.keywordAuthor | Process characterization | - |
dc.subject.keywordAuthor | Design space | - |
dc.subject.keywordAuthor | Perfusion culture | - |
dc.subject.keywordAuthor | Recombinant Factor FVIII | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.